View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
 PRESS RELEASE

TherapeuticsMD Announces Submission of Low Dose BIJUVA® 0.5 mg/100 mg ...

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare company, announced today that the Company submitted a supplemental New Drug Application (“sNDA”) for BIJUVA (estradiol and progesterone) capsules, 0.5 mg/100 mg, to the U.S. Food and Drug Administration (“FDA”). The Company expects to learn of the acceptance of the sNDA upon receipt of the Filing Review Notification from the FDA, approximately 74 days after submission. If accepted, the Company expects that the review time under the Prescription Drug User Fee Act (PDUFA) will be w...

 PRESS RELEASE

The Sun Sentinel Names TherapeuticsMD, Inc. a Winner of the South Flor...

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), has been awarded a Top Workplaces 2021 honor by The Sun Sentinel. The list is based solely on gathered through a third-party survey administered by employee engagement technology partner , LLC. The anonymous survey uniquely measures 15 culture drivers that are critical to the success of any organization including alignment, execution, and connection. “During this very challenging time, Top Workplaces has proven to be a beacon of light for organizations, as well as a sign of resiliency and strong business performance,” s...

 PRESS RELEASE

TherapeuticsMD Announces First Quarter 2021 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative, leading women’s healthcare Company, today reported financial results for the first quarter ended March 31, 2021. “I am pleased with our ongoing execution across the organization, which is in-line with our 2021 operating plan led by ANNOVERA, which performed well in a challenging environment. Our financial performance continues to improve year-over-year. Both menopausal products, IMVEXXY and BIJUVA, had record net revenue per unit. We are also pleased to report that three new ANNOVERA patents were obtained,...

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: June 13, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

1A80 ACCELERATE DIAGNOSTICS INC.
TXMD THERAPEUTICSMD INC.
SANW S&W SEED CO
PNFP PINNACLE FINANCIAL PARTNERS INC.
ORI OLD REPUBLIC INTERNATIONAL CORPORATION
4LT1 NORTHERN OIL & GAS INC.
LQDT LIQUIDITY SERVICES
FOSL FOSSIL GROUP INC.
FGEN FIBROGEN INC.
EXTR EXTREME NETWORKS INC.
AVID AVID TECHNOLOGY INC.
ATO ATMOS ENERGY CORPORATION
ASB ASSOCIATED BANC-CORP
AMRS AMYRIS
AMG AFFILIATED MANAGERS GROUP INC.
ADS ALLIANCE DATA SYSTEMS CORPORATION
AMWD AMERICAN WOODMARK CORPORATION
CERC CERECOR INC
CNA CNA FINANCIAL CORPORATION
CCV COUNTERPATH
FLXS FLEXSTEEL INDUSTRIES INC.
LSXMA LIBERTY MEDIA CORP. SERIES A LIBERTY SIRIUSXM
RILY B RILEY SECURITIES INC
CNBKA CENTURY BANCORP INC. CL A
CWH CAMPING WORLD HOLDINGS INC. CLASS A
PHD PIONEER FLOATING RATE
CDEV CENTENNIAL RESOURCE DEVELOPMENT INC. CLASS A
MRUS MERUS B V
ATH ATHENE HOLDING LTD. CLASS A
CLRB CELLECTAR BIOSCIENCES
KALA KALA PHARMACEUTICALS INC.
ALRN AILERON THERAPEUTICS
RCUS ARCUS BIOSCIENCES
MNLO MENLO THERAPEUTICS INC
BHC BAUSCH HEALTH COMPANIES INC.
KZR KEZAR LIFE SCIENCES
ETTX ENTASIS THERAPEUTICS HOLDINGS
REZI RESIDEO TECHNOLOGIES
KLDO INC.
APRN KALEIDO BIOSCIENCES
BW BLUE APRON HOLDINGS
WTRE BABCOCK & WILCOX ENTERPRISES
ARCT WATFORD HOLDINGS
CHNG ARCTURUS THERAPEUTICS HOLDINGS INC
LSXMK CHANGE HEALTHCARE INC.
EVF LIBERTY MEDIA CORP. SERIES C LIBERTY SIRIUSXM
CLDX EATON VANCE SENIOR INCOME TRUST
APDN CELLDEX THERAPEUTICS INC.
SONM APPLIED DNA SCIENCES INC.
BCSF SONIM TECHNOLOGIES
CRDB BAIN CAPITAL SPECIALTY FINANCE
SIC CRAWFORD & COMPANY
MCACU SELECT INTERIOR CONCEPTS
MOUNTAIN CREST ACQUISITION CORP.
Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: June 10, 2020

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: October 29, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: August 24, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Weekly Tables: August 17, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

InsiderInsights Daily Ratings Report: August 15, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

Jonathan Moreland
  • Jonathan Moreland

Monthly Insider Special Screens: Jan 1, 2019

InsiderInsights Ratings of Companies with Open-Market Form 4 Purchases; Sales Filed at the SEC on the date above. We separate the real investment intelligence from the noise. Saving you time, and improving your research process

 PRESS RELEASE

TherapeuticsMD Announces First Quarter 2018 Financial Results

BOCA RATON, Fla.--(BUSINESS WIRE)-- TherapeuticsMD, Inc. (NASDAQ: TXMD), an innovative women’s healthcare company, today announced its financial results for the quarter ended March 31, 2018. First Quarter and Recent Developments Entered into a definitive loan agreement with MidCap Financial, managed by Apollo Capital Management, L.P., for $200 million in non-dilutive term loan financing. The term loan will be available to the company in three tranches following specific milestones through Dece...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch